SARS_CoV_2 mutation literature information.


  Molecular and Epidemiological Characterization of Emerging Immune-Escape Variants of SARS-CoV-2.
 PMID: 35223905       2022       Frontiers in medicine
Method: For instance, a Delta variant spike haplotype consisting of T19R, 256_258delinsG,
Result: At 1 week after vaccination, strong neutralization (hiVNT score > 70) of all variants was observed in most of the sera samples, ranging from the highest (95.2%) in D614G to the lowest in the Beta variant (70.6 %) (Figure 3).
Result: The geometric mean titers (GMTs) were 225 for D614G, 38 for Beta, and 37 for Delta + E484K + N501Y (Figure 2A), suggesting that the sera had 6-fold reduced neutralization efficacy against the Beta and Delta variants.


  Variants of SARS CoV-2: mutations, transmissibility, virulence, drug resistance, and antibody/vaccine sensitivity.
 PMID: 35227008       2022       Frontiers in bioscience (Landmark edition)
Abstract: Mutations in the S protein that are common among several of the variants include D614G that increases transmissibility and viral load and is often associated with P323L on the RNA dependent RNA polymerase.


  In-silico genomic landscape characterization and evolution of SARS-CoV-2 variants isolated in India shows significant drift with high frequency of mutations.
 PMID: 35233173       2022       Saudi journal of biological sciences
Abstract: The most frequent non-synonymous mutation 486/546 (89.01%) occurred in the S gene (structural gene) at position 23,403 where A changed to G leading to the replacement of aspartic acid by glycine in position (D614G).
Result: The most frequent non-synonymous mutation 486/546 (89.01%) occurred in the S gene at position 23,403 where A changed to G leading to the replacement of aspartic acid by glycine in position (D614G)) Table 3 and.
Table: D614G


  SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivity.
 PMID: 35233544       2022       Cell reports. Medicine
Discussion: Here, we showed preservation of Fc effector function against VOCs both in individuals previously infected with the original D614G variant and in individuals vaccinated with Ad26.COV2.S.
Discussion: This is supported by a recent study measuring natural killer (NK) activation, ADCP, ADCD, and ADCC in Ad26.COV2.S vaccinees showing differences of under 2-fold between original D614G and Beta.
Discussion: This was despite the fact that the sequence of immunodominant regions of the eliciting immunogens were the same, with only the single D614G mutation differing between them.


  Rapidly Identifying New Coronavirus Mutations of Potential Concern in the Omicron Variant Using an Unsupervised Learning Strategy.
 PMID: 35233566       2022       Research square
Abstract: To build an investigative framework, we have applied an unsupervised machine learning approach to 4296 Omicron viral genomes collected and deposited to GISAID as of December 14, 2021, and have identified a core haplotype of 28 polymutants (A67V, T95I, G339D, R346K, S371L, S373P, S375F, K417N,
Introduction: Note that we use a polymutant nomenclature without the ending amino acid designated, e.g., D614 as opposed to D614G, because several polymutants exhibit multiple mutations.
Introduction: Some, like D614G, are observed in all three variant families and the impact of this mutation has been well documented.


  "VE607 Stabilizes SARS-CoV-2 Spike In the ""RBD-up"" Conformation and Inhibits Viral Entry."
 PMID: 35233570       2022       bioRxiv
Abstract: The IC 50 values are in the low micromolar range for pseudoparticles derived from SARS-CoV-2 Wuhan/D614G as well as from variants of concern (Alpha, Beta, Gamma, Delta and Omicron), suggesting that VE607 has potential for the development of drugs against SARS-CoV-2 infections.


  Travel ban effects on SARS-CoV-2 transmission lineages in the UAE as inferred by genomic epidemiology.
 PMID: 35235585       2022       PloS one
Abstract: The study comprehensively characterized the genomic aspects of the virus and its spread within the UAE and identified that the prevalence shift of the D614G mutation was due to the later introductions of the G-variant associated with international travel, rather than higher local transmissibility.
Conclusion: Moreover, we report a prevalence shift in D614G, but attribute it to change of import origins rather than higher transmissibility of the G-variant.
Result: In addition to the above-mentioned D614G mutation, we observe four cases of a nearby E583D mutation, that could be of diagnostic or clinical relevance (transmissibility and severity).


  Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
 PMID: 35236358       2022       BMC medicine
Abstract: In addition, the neutralization efficacy of authentic SARS-CoV-2 wild type (D614G), Delta, and Omicron by sera from 2x or 3x BNT162b2-vaccinated persons was analyzed.
Result: The neutralization of authentic SARS-CoV-2 wt (with D614G mutation), Delta, and Omicron was analyzed using sera of 2x BNT162b-vaccinated and BNT162b2 boost-vaccinated individuals.
Figure: Neutralization of SARS-CoV-2 wild type (D614G), Delta, and Omicron.


  Antibody evasion properties of SARS-CoV-2 Omicron sublineages.
 PMID: 35240676       2022       Nature
Introduction: Among these samples, the mean serum neutralizing titres against Omicron sublineages were significantly lower than the mean titre for D614G; although the mean titre was slightly lower for BA.2, the difference from that of the BA.1 sublineages did not reach statistical significance (P = 0.242).
Introduction: As above, neutralizing titres dropped significantly against authentic BA.2 virus relative to D614G.
Introduction: The wild-type D614G pseudovirus was included as a comparator.


  Antibody escape and global spread of SARS-CoV-2 lineage A.27.
 PMID: 35241661       2022       Nature communications
Introduction: A.27 is characterized by a mutational profile including L18F, L452R and N501Y in the S protein that combines genetic changes found in various VOCs/VOIs, while lacking the D614G substitution present in most other lineages.
Introduction: Early in the pandemic, SARS-CoV-2 acquired the S D614G substitution that has been associated with increased transmissibility and set the genetic foundation for the large number of B.1 derived lineages.
Introduction: These variants are characterized by specific patterns of concerning S mutations: apart from the D614G substitution, lineage B.1.1.7 has the N501Y amino acid substitution asso



Browser Board

 Co-occurred Entities




   Filtrator